Abstract | OBJECTIVE: METHODS: The serum metabolic profiles of 352 women with overweight or obesity participating in a mother-infant clinical study were analyzed with a targeted NMR approach (at 35.1 median gestational weeks). GDM was diagnosed with a 2-hour 75-g oral glucose tolerance test. RESULTS: The metabolomic profile of the women with GDM (n = 100) deviated from that of women without GDM (n = 252). Differences were seen in 70 lipid variables, particularly higher concentrations of very low-density lipoprotein particles and serum triglycerides were related to GDM. Furthermore, levels of branched-chain amino acids and glycoprotein acetylation, a marker of low-grade inflammation, were higher in women with GDM. Compared with women with GDM treated with diet only, the women treated with medication (n = 19) had higher concentrations of severalizes of VLDL particles and their components, leucine, and isoleucine, as well as glycoprotein acetylation. CONCLUSIONS: A clearly distinct metabolic profile was detected in GDM, which deviated even more if the patient was receiving medical treatment. This suggests a need for more intense follow-up and therapy for women with GDM during pregnancy and postpartum to reduce their long-term adverse health risks.
|
Authors | Kati Mokkala, Tero Vahlberg, Noora Houttu, Ella Koivuniemi, Kirsi Laitinen |
Journal | Obesity (Silver Spring, Md.)
(Obesity (Silver Spring))
Vol. 28
Issue 9
Pg. 1637-1644
(09 2020)
ISSN: 1930-739X [Electronic] United States |
PMID | 32705820
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2020 The Authors. Obesity published by Wiley Periodicals LLC on behalf of The Obesity Society (TOS). |
Topics |
- Adult
- Diabetes, Gestational
(metabolism, therapy)
- Female
- Humans
- Metabolomics
(methods)
- Obesity
(therapy)
- Overweight
(therapy)
- Pregnancy
|